Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification-Reference-Cited by-同舟云学术

Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification

Published:2015-11 Issue:2 Volume:39 Page:85-91
ISSN:1058-9813
Container-title:Progress in Pediatric Cardiology
language:en
Short-container-title:Progress in Pediatric Cardiology

Author:

Petricoin Emanuel F.,Ross Mark M.,Zhou Weidong,Tamburro Davide,Luchini Alessandra,Liotta Lance A.,Herman Eugene H.,Scully Rebecca E.,Miller Tracie L.,Franco Vivian I.,Sallan Stephen E.,Lipshultz Steven E.

Funder

National Institutes of Health

Novartis Diagnostics, Inc

Pfizer Pharmaceuticals, Inc.

Roche Diagnostics Corporation

Lance Armstrong Foundation

Women's Cancer Association

Scott Howard Fund

Parker Family Foundation

Michael Garil Fund

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology and Child Health

Reference39 articles.

1. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management;Barry;Expert. Opin. Pharmacother.,2007

2. Anthracycline associated cardiotoxicity in survivors of childhood cancer;Lipshultz;Heart,2008

3. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia;Lipshultz;J. Clin. Oncol.,2005

4. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood;Lipshultz;N. Engl. J. Med.,1991

5. Chronic health conditions in adult survivors of childhood cancer;Oeffinger;N. Engl. J. Med.,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review;Current Drug Metabolism;2017-03-31

2. Late Cardiac Effects in Childhood Cancer Survivors;Cardio-Oncology;2017